Factors influencing cure rates of non‐dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment
Objectives Onychomycosis shows a poor response to current topical, oral, or device‐related antifungal therapies. The aim of this study was to identify factors influencing the cure rates of non‐dermatophyte mold and Candida onychomycosis. Methods Eighty‐one patients who completed treatments were divi...
Gespeichert in:
Veröffentlicht in: | International journal of dermatology 2017-02, Vol.56 (2), p.202-208 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 208 |
---|---|
container_issue | 2 |
container_start_page | 202 |
container_title | International journal of dermatology |
container_volume | 56 |
creator | Ranawaka, Ranthilaka R. Silva, S. H. Padmal |
description | Objectives
Onychomycosis shows a poor response to current topical, oral, or device‐related antifungal therapies. The aim of this study was to identify factors influencing the cure rates of non‐dermatophyte mold and Candida onychomycosis.
Methods
Eighty‐one patients who completed treatments were divided into “cured” and “non‐cured” groups. The statistical significance of differences between the two groups was studied.
Results
Male gender (P < 0.01), long duration of disease before the initiation of treatment (P < 0.02), three or more infected nails (P < 0.0002), continuous exposure to water and detergents (P < 0.05), frequent exposure to mud and soil (P < 0.01), barefoot walking (P < 0.025), concomitant diabetes and hypertension (P < 0.04), eczema (P < 0.03), and associated paronychia (P < 0.01) had negative effects on cure rates of onychomycosis. Patient age, occupation, site of illness (hand, foot or big toe), type of disease (distal and lateral subungual onychomycosis, proximal subungual onychomycosis or total dystrophic onychomycosis), pathogenic fungi, and treatment modality had no statistically significant impact on cure rate.
Conclusions
To minimize the failure rate of antifungal therapies in the treatment of onychomycosis, patients are advised to start treatment as soon as possible, and to avoid predisposing factors such as exposure to water, detergents, mud and soil, and barefoot walking. |
doi_str_mv | 10.1111/ijd.13426 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1868317052</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1836727740</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3466-998a8f4ae9af43d436dad4093e93a6d75934b78e15ac4604e57fed12ad9452cb3</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS1ERaeFBS-ALLGhi7T-ixOzq6YtFFViA-vIY98wHiV2sB1V2fEIfUaeBA9TWFRC4i58r3W-eyz5IPSaknNa6sLt7DnlgslnaEW5rCshOXuOVoRQWilSq2N0ktKuXDmj4gU6Zk1LOZFihR5utMkhJux8P8zgjfPfsJkj4KgzJBx67IP_-ePBQhx1DtN2yYDHMFisvcXrcjircfCL2YZxMSG59L5IeljKtF8PczZhhP0LuKV40tmBzwnfbwMuwjRABotzBJ3HIrxER70eErx67Kfo6831l_XH6u7zh9v15V1luJCyUqrVbS80KN0LbgWXVltBFAfFtbRNrbjYNC3QWhshiYC66cFSpq0SNTMbforeHXynGL7PkHI3umRgGLSHMKeOtrLltCE1-w-Uy4Y1jSAFffsE3YU5lt8olGJEtIwxWaizA2ViSClC303RjTouHSXdPtGuJNr9TrSwbx4d580I9i_5J8ICXByAezfA8m-n7vbT1cHyFx-hrLE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1920482226</pqid></control><display><type>article</type><title>Factors influencing cure rates of non‐dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Ranawaka, Ranthilaka R. ; Silva, S. H. Padmal</creator><creatorcontrib>Ranawaka, Ranthilaka R. ; Silva, S. H. Padmal</creatorcontrib><description><![CDATA[Objectives
Onychomycosis shows a poor response to current topical, oral, or device‐related antifungal therapies. The aim of this study was to identify factors influencing the cure rates of non‐dermatophyte mold and Candida onychomycosis.
Methods
Eighty‐one patients who completed treatments were divided into “cured” and “non‐cured” groups. The statistical significance of differences between the two groups was studied.
Results
Male gender (P < 0.01), long duration of disease before the initiation of treatment (P < 0.02), three or more infected nails (P < 0.0002), continuous exposure to water and detergents (P < 0.05), frequent exposure to mud and soil (P < 0.01), barefoot walking (P < 0.025), concomitant diabetes and hypertension (P < 0.04), eczema (P < 0.03), and associated paronychia (P < 0.01) had negative effects on cure rates of onychomycosis. Patient age, occupation, site of illness (hand, foot or big toe), type of disease (distal and lateral subungual onychomycosis, proximal subungual onychomycosis or total dystrophic onychomycosis), pathogenic fungi, and treatment modality had no statistically significant impact on cure rate.
Conclusions
To minimize the failure rate of antifungal therapies in the treatment of onychomycosis, patients are advised to start treatment as soon as possible, and to avoid predisposing factors such as exposure to water, detergents, mud and soil, and barefoot walking.]]></description><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.13426</identifier><identifier>PMID: 27813064</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antifungal Agents - therapeutic use ; Aspergillosis - complications ; Aspergillosis - drug therapy ; Candida ; Candidiasis - complications ; Candidiasis - drug therapy ; Candidiasis - microbiology ; Detergents ; Diabetes Complications - complications ; Diabetes mellitus ; Eczema ; Eczema - complications ; Exposure ; Feet ; Female ; Foot Dermatoses - drug therapy ; Foot Dermatoses - microbiology ; Fungi ; Fungicides ; Fusariosis - complications ; Fusariosis - drug therapy ; Hand Dermatoses - drug therapy ; Hand Dermatoses - microbiology ; Humans ; Hypertension ; Hypertension - complications ; Itraconazole - therapeutic use ; Male ; Middle Aged ; Mud ; Nails (Anatomy) ; Naphthalenes - therapeutic use ; Onychomycosis ; Onychomycosis - drug therapy ; Onychomycosis - microbiology ; Paronychia ; Paronychia - complications ; Patients ; Risk Factors ; Skin diseases ; Soil ; Soil water ; Soils ; Statistical analysis ; Statistical significance ; Time-to-Treatment ; Toe ; Treatment Outcome ; Walking ; Water ; Young Adult</subject><ispartof>International journal of dermatology, 2017-02, Vol.56 (2), p.202-208</ispartof><rights>2016</rights><rights>2016 The International Society of Dermatology.</rights><rights>International Journal of Dermatology © 2017 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3466-998a8f4ae9af43d436dad4093e93a6d75934b78e15ac4604e57fed12ad9452cb3</cites><orcidid>0000-0002-2416-3547</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijd.13426$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijd.13426$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27813064$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ranawaka, Ranthilaka R.</creatorcontrib><creatorcontrib>Silva, S. H. Padmal</creatorcontrib><title>Factors influencing cure rates of non‐dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment</title><title>International journal of dermatology</title><addtitle>Int J Dermatol</addtitle><description><![CDATA[Objectives
Onychomycosis shows a poor response to current topical, oral, or device‐related antifungal therapies. The aim of this study was to identify factors influencing the cure rates of non‐dermatophyte mold and Candida onychomycosis.
Methods
Eighty‐one patients who completed treatments were divided into “cured” and “non‐cured” groups. The statistical significance of differences between the two groups was studied.
Results
Male gender (P < 0.01), long duration of disease before the initiation of treatment (P < 0.02), three or more infected nails (P < 0.0002), continuous exposure to water and detergents (P < 0.05), frequent exposure to mud and soil (P < 0.01), barefoot walking (P < 0.025), concomitant diabetes and hypertension (P < 0.04), eczema (P < 0.03), and associated paronychia (P < 0.01) had negative effects on cure rates of onychomycosis. Patient age, occupation, site of illness (hand, foot or big toe), type of disease (distal and lateral subungual onychomycosis, proximal subungual onychomycosis or total dystrophic onychomycosis), pathogenic fungi, and treatment modality had no statistically significant impact on cure rate.
Conclusions
To minimize the failure rate of antifungal therapies in the treatment of onychomycosis, patients are advised to start treatment as soon as possible, and to avoid predisposing factors such as exposure to water, detergents, mud and soil, and barefoot walking.]]></description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Aspergillosis - complications</subject><subject>Aspergillosis - drug therapy</subject><subject>Candida</subject><subject>Candidiasis - complications</subject><subject>Candidiasis - drug therapy</subject><subject>Candidiasis - microbiology</subject><subject>Detergents</subject><subject>Diabetes Complications - complications</subject><subject>Diabetes mellitus</subject><subject>Eczema</subject><subject>Eczema - complications</subject><subject>Exposure</subject><subject>Feet</subject><subject>Female</subject><subject>Foot Dermatoses - drug therapy</subject><subject>Foot Dermatoses - microbiology</subject><subject>Fungi</subject><subject>Fungicides</subject><subject>Fusariosis - complications</subject><subject>Fusariosis - drug therapy</subject><subject>Hand Dermatoses - drug therapy</subject><subject>Hand Dermatoses - microbiology</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Itraconazole - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mud</subject><subject>Nails (Anatomy)</subject><subject>Naphthalenes - therapeutic use</subject><subject>Onychomycosis</subject><subject>Onychomycosis - drug therapy</subject><subject>Onychomycosis - microbiology</subject><subject>Paronychia</subject><subject>Paronychia - complications</subject><subject>Patients</subject><subject>Risk Factors</subject><subject>Skin diseases</subject><subject>Soil</subject><subject>Soil water</subject><subject>Soils</subject><subject>Statistical analysis</subject><subject>Statistical significance</subject><subject>Time-to-Treatment</subject><subject>Toe</subject><subject>Treatment Outcome</subject><subject>Walking</subject><subject>Water</subject><subject>Young Adult</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhS1ERaeFBS-ALLGhi7T-ixOzq6YtFFViA-vIY98wHiV2sB1V2fEIfUaeBA9TWFRC4i58r3W-eyz5IPSaknNa6sLt7DnlgslnaEW5rCshOXuOVoRQWilSq2N0ktKuXDmj4gU6Zk1LOZFihR5utMkhJux8P8zgjfPfsJkj4KgzJBx67IP_-ePBQhx1DtN2yYDHMFisvcXrcjircfCL2YZxMSG59L5IeljKtF8PczZhhP0LuKV40tmBzwnfbwMuwjRABotzBJ3HIrxER70eErx67Kfo6831l_XH6u7zh9v15V1luJCyUqrVbS80KN0LbgWXVltBFAfFtbRNrbjYNC3QWhshiYC66cFSpq0SNTMbforeHXynGL7PkHI3umRgGLSHMKeOtrLltCE1-w-Uy4Y1jSAFffsE3YU5lt8olGJEtIwxWaizA2ViSClC303RjTouHSXdPtGuJNr9TrSwbx4d580I9i_5J8ICXByAezfA8m-n7vbT1cHyFx-hrLE</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Ranawaka, Ranthilaka R.</creator><creator>Silva, S. H. Padmal</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope><scope>M7N</scope><orcidid>https://orcid.org/0000-0002-2416-3547</orcidid></search><sort><creationdate>201702</creationdate><title>Factors influencing cure rates of non‐dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment</title><author>Ranawaka, Ranthilaka R. ; Silva, S. H. Padmal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3466-998a8f4ae9af43d436dad4093e93a6d75934b78e15ac4604e57fed12ad9452cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Aspergillosis - complications</topic><topic>Aspergillosis - drug therapy</topic><topic>Candida</topic><topic>Candidiasis - complications</topic><topic>Candidiasis - drug therapy</topic><topic>Candidiasis - microbiology</topic><topic>Detergents</topic><topic>Diabetes Complications - complications</topic><topic>Diabetes mellitus</topic><topic>Eczema</topic><topic>Eczema - complications</topic><topic>Exposure</topic><topic>Feet</topic><topic>Female</topic><topic>Foot Dermatoses - drug therapy</topic><topic>Foot Dermatoses - microbiology</topic><topic>Fungi</topic><topic>Fungicides</topic><topic>Fusariosis - complications</topic><topic>Fusariosis - drug therapy</topic><topic>Hand Dermatoses - drug therapy</topic><topic>Hand Dermatoses - microbiology</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Itraconazole - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mud</topic><topic>Nails (Anatomy)</topic><topic>Naphthalenes - therapeutic use</topic><topic>Onychomycosis</topic><topic>Onychomycosis - drug therapy</topic><topic>Onychomycosis - microbiology</topic><topic>Paronychia</topic><topic>Paronychia - complications</topic><topic>Patients</topic><topic>Risk Factors</topic><topic>Skin diseases</topic><topic>Soil</topic><topic>Soil water</topic><topic>Soils</topic><topic>Statistical analysis</topic><topic>Statistical significance</topic><topic>Time-to-Treatment</topic><topic>Toe</topic><topic>Treatment Outcome</topic><topic>Walking</topic><topic>Water</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ranawaka, Ranthilaka R.</creatorcontrib><creatorcontrib>Silva, S. H. Padmal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ranawaka, Ranthilaka R.</au><au>Silva, S. H. Padmal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors influencing cure rates of non‐dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment</atitle><jtitle>International journal of dermatology</jtitle><addtitle>Int J Dermatol</addtitle><date>2017-02</date><risdate>2017</risdate><volume>56</volume><issue>2</issue><spage>202</spage><epage>208</epage><pages>202-208</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><abstract><![CDATA[Objectives
Onychomycosis shows a poor response to current topical, oral, or device‐related antifungal therapies. The aim of this study was to identify factors influencing the cure rates of non‐dermatophyte mold and Candida onychomycosis.
Methods
Eighty‐one patients who completed treatments were divided into “cured” and “non‐cured” groups. The statistical significance of differences between the two groups was studied.
Results
Male gender (P < 0.01), long duration of disease before the initiation of treatment (P < 0.02), three or more infected nails (P < 0.0002), continuous exposure to water and detergents (P < 0.05), frequent exposure to mud and soil (P < 0.01), barefoot walking (P < 0.025), concomitant diabetes and hypertension (P < 0.04), eczema (P < 0.03), and associated paronychia (P < 0.01) had negative effects on cure rates of onychomycosis. Patient age, occupation, site of illness (hand, foot or big toe), type of disease (distal and lateral subungual onychomycosis, proximal subungual onychomycosis or total dystrophic onychomycosis), pathogenic fungi, and treatment modality had no statistically significant impact on cure rate.
Conclusions
To minimize the failure rate of antifungal therapies in the treatment of onychomycosis, patients are advised to start treatment as soon as possible, and to avoid predisposing factors such as exposure to water, detergents, mud and soil, and barefoot walking.]]></abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>27813064</pmid><doi>10.1111/ijd.13426</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2416-3547</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0011-9059 |
ispartof | International journal of dermatology, 2017-02, Vol.56 (2), p.202-208 |
issn | 0011-9059 1365-4632 |
language | eng |
recordid | cdi_proquest_miscellaneous_1868317052 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Adult Aged Aged, 80 and over Antifungal Agents - therapeutic use Aspergillosis - complications Aspergillosis - drug therapy Candida Candidiasis - complications Candidiasis - drug therapy Candidiasis - microbiology Detergents Diabetes Complications - complications Diabetes mellitus Eczema Eczema - complications Exposure Feet Female Foot Dermatoses - drug therapy Foot Dermatoses - microbiology Fungi Fungicides Fusariosis - complications Fusariosis - drug therapy Hand Dermatoses - drug therapy Hand Dermatoses - microbiology Humans Hypertension Hypertension - complications Itraconazole - therapeutic use Male Middle Aged Mud Nails (Anatomy) Naphthalenes - therapeutic use Onychomycosis Onychomycosis - drug therapy Onychomycosis - microbiology Paronychia Paronychia - complications Patients Risk Factors Skin diseases Soil Soil water Soils Statistical analysis Statistical significance Time-to-Treatment Toe Treatment Outcome Walking Water Young Adult |
title | Factors influencing cure rates of non‐dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T17%3A31%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20influencing%20cure%20rates%20of%20non%E2%80%90dermatophyte%20mold%20and%20Candida%20onychomycosis:%20analysis%20of%20outcomes%20in%2081%20patients%20who%20completed%20treatment&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Ranawaka,%20Ranthilaka%20R.&rft.date=2017-02&rft.volume=56&rft.issue=2&rft.spage=202&rft.epage=208&rft.pages=202-208&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.13426&rft_dat=%3Cproquest_cross%3E1836727740%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1920482226&rft_id=info:pmid/27813064&rfr_iscdi=true |